EGFR and non-small cell lung carcinoma: In this study, we evaluated the diagnostic usefulness of the focused targeted NGS panel for detection of actionable EGFR variants in a number of clinical tissue samples from advanced NSCLC patients previously analyzed using the In Vitro Diagnostic (IVD)-certified qPCR test with respect to the NSCLC cell lines and the biosynthetic DNA reference material.